Generate a tailored SOP for Dr. Mary Rinella. Improve your application with a focused, well-structured draft.
Mary E. Rinella, MD, is a Professor in the Medicine Department at the University of Chicago, focusing on Gastroenterology, Hepatology, and Nutrition. She has been part of the faculty since January 2021, serving as the Director of the Metabolic Fatty Liver Program and overseeing the Clinical Trials section. Dr. Rinella has held significant leadership positions within national societies, including serving on the Governing Board of the American Association for the Study of Liver Disease (AASLD). As a lead author, she contributed to the 2023 AASLD Clinical Practice Guidance for the diagnosis and management of Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Associated Steatotic Liver Disease (MASLD). She has played a key role in revising the nomenclature surrounding NAFLD and chaired the AASLD's task force on Steatotic Liver Disease. Her clinical focus is on metabolic liver diseases, with notable expertise in cholestatic liver disease, primary biliary cholangitis, primary sclerosing cholangitis, autoimmune liver disease, and complications arising from cirrhosis and portal hypertension. Dr. Rinella is committed to enhancing disease awareness, practice dissemination, and developing strategies for improving care outcomes for patients with steatotic liver disease through collaborative efforts in clinical settings and ongoing research.
Department of Philosophy